Altered levels of the soluble IL-1, IL-4 and TNF receptors, as well as the IL-1 receptor antagonist, in intermittent allergic rhinitis

被引:16
|
作者
Benson, M [1 ]
Wennergren, G
Fransson, M
Cardell, LO
机构
[1] Queen Silvia Childrens Hosp, Pediat Allergy Res Grp, SE-41685 Gothenburg, Sweden
[2] Lund Univ, Malmo Univ Hosp, Dept Otorhinolaryngol, Lab Clin & Expt Allergol, Malmo, Sweden
关键词
cytokines; soluble; interleukins; receptors; rhinitis;
D O I
10.1159/000078770
中图分类号
R392 [医学免疫学];
学科分类号
100102 ;
摘要
Background: The effects of cytokines are modulated by soluble cytokine receptors (SCR) and receptor antagonists. Therefore, allergic disease may depend on altered proportions between cytokines, their SCR and receptor antagonists, rather than absolute changes in cytokine levels. Little is known about SCR in intermittent allergic rhinitis (IAR). Objective: To examine the concentrations of SCR, i.e. sIL-1R2, sIL-4R, sIL-6R and sTNFR1, as well as the interleukin-1 receptor antagonist (IL-1Ra) in nasal fluids from allergen-challenged patients with IAR and healthy controls. Methods: 30 patients with birch- or grass-pollen-induced IAR and 30 healthy controls were studied. In the patients nasal fluids were obtained before as well as 1 and 6 h after allergen provocation. Results: Both symptom scores and rhinoscopic signs of rhinitis increased in the patients after allergen challenge. Comparisons between patients and controls showed that sIL-4R was lower in patients before and 1 and 6 h after provocation. IL-1Ra was lower before and 1 h after provocation. In addition, lower concentrations of sTNFR1 were found in patients after 1 h, while sIL-1R2 concentrations were higher after 1 h. Comparisons of patients before and after challenge showed that IL-1Ra and sTNFR1 decreased after 1 h, while sIL-1R2 increased. No significant differences were found compared to 6 h. sIL-6R did not significantly differ between the study groups. Conclusions: After allergen challenge, significant changes in the nasal fluid levels of IL-1Ra, sIL-1R2 and sTNFR1 were found. By contrast, sIL-4R remained at lower levels than in controls both before and after challenge. Since sIL-4R modulates IgE synthesis, this may play a role in the pathogenesis of IAR. Copyright (C) 2004 S. Karger AG, Basel.
引用
收藏
页码:227 / 232
页数:6
相关论文
共 50 条
  • [41] Polymorphisms for interleukin-1β (IL-1β)-511 promoter, IL-1β exon 5, and IL-1 receptor antagonist:: Nonassociation with endometriosis
    Hsieh, YY
    Chang, CC
    Tsai, FJ
    Wu, JY
    Shi, YR
    Tsai, HD
    Tsai, CH
    JOURNAL OF ASSISTED REPRODUCTION AND GENETICS, 2001, 18 (09) : 506 - 511
  • [44] Crystal structure of an IL-1 receptor antagonist peptide complexed with IL-1 receptor type I
    Brandhuber, BJ
    Dripps, DJ
    Edwards, CK
    Vigers, GPA
    FASEB JOURNAL, 2000, 14 (08): : A1394 - A1394
  • [45] Interleukin-1α (IL-1α), IL-1β, IL-1 receptor type I, IL-1 receptor antagonist, and TGF-β1 mRNAs in pediatric astrocytomas, ependymomas, and primitive neuroectodermal tumors
    Ilyin, SE
    Gonzalez-Gomez, I
    Gilles, FH
    Plata-Salaman, CR
    MOLECULAR AND CHEMICAL NEUROPATHOLOGY, 1998, 33 (02) : 125 - 137
  • [46] The pattern of interleukin-1 beta (IL-1 beta) and its modulating agents IL-1 receptor antagonist and IL-1 soluble receptor type II in acute meningococcal infections
    vanDeuren, M
    vanderVenJongekrijg, J
    Vannier, E
    vanDalen, R
    Pesman, G
    Bartelink, AKM
    Dinarello, CA
    vanderMeer, JWM
    BLOOD, 1997, 90 (03) : 1101 - 1108
  • [47] INTERLEUKIN-1 (IL-1) RECEPTOR ANTAGONIST BINDS TO THE 80-KDA IL-1 RECEPTOR BUT DOES NOT INITIATE IL-1 SIGNAL TRANSDUCTION
    DRIPPS, DJ
    BRANDHUBER, BJ
    THOMPSON, RC
    EISENBERG, SP
    JOURNAL OF BIOLOGICAL CHEMISTRY, 1991, 266 (16) : 10331 - 10336
  • [48] Inhibitory activity of IL-1 receptor antagonist depends on the balance between binding capacity for IL-1 receptor type 1 and IL-1 receptor type II
    Ruggiero, P
    Bossu, P
    Macchia, G
    DelGrosso, E
    Sabbatini, V
    Bertini, R
    Colagrande, A
    Bizzarri, C
    Maurizi, G
    DiCioccio, V
    DAndrea, G
    DiGiulio, A
    Frigerio, F
    Grifantini, R
    Grandi, G
    Tagliabue, A
    Boraschi, D
    JOURNAL OF IMMUNOLOGY, 1997, 158 (08): : 3881 - 3887
  • [49] AN IL-1 RECEPTOR AND AN IL-1 RECEPTOR ANTAGONIST ATTENUATE MURAMYL DIPEPTIDE- AND IL-1-INDUCED SLEEP AND FEVER
    IMERI, L
    OPP, MR
    KRUEGER, JM
    AMERICAN JOURNAL OF PHYSIOLOGY, 1993, 265 (04): : R907 - R913
  • [50] Genetic control of IL-1β bioactivity through differential regulation of the IL-1 receptor antagonist
    Vamvakopoulos, J
    Green, C
    Metcalfe, S
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2002, 32 (10) : 2988 - 2996